Page last updated: 2024-08-26

n-glycylalanine and Disease Models, Animal

n-glycylalanine has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, PO; Bieniek, KF; Boylan, KB; Castanedes-Casey, M; Chew, J; Daughrity, LM; Desaro, P; Dickson, DW; Edbauer, D; Fryer, JD; Gendron, TF; Jansen-West, K; Johnston, A; Kurti, A; Lee, CW; Murray, ME; Overstreet, K; Perkerson, EA; Petrucelli, L; Prudencio, M; Rademakers, R; Rousseau, L; Sasaguri, H; Stankowski, JN; Stetler, C; Whitelaw, EC; Zhang, YJ1

Other Studies

1 other study(ies) available for n-glycylalanine and Disease Models, Animal

ArticleYear
Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.
    Science (New York, N.Y.), 2015, Jun-05, Volume: 348, Issue:6239

    Topics: Amyotrophic Lateral Sclerosis; Animals; Antisocial Personality Disorder; C9orf72 Protein; Cerebral Cortex; Dependovirus; Dipeptides; Disease Models, Animal; DNA-Binding Proteins; Frontotemporal Dementia; Gene Transfer Techniques; HEK293 Cells; Humans; Mice; Proteins; Purkinje Cells; RNA, Nuclear

2015